AACR: Penn Medicine Preclinical Study Identifies New Target for Recurrent Ovarian Cancer
Perelman School of Medicine at the University of PennsylvaniaResults from a preclinical study from Penn Medicine, presented at the AACR Annual Meeting 2023, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.